Winfield Associates’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLUE
Winfield Associates's BLUE Position: Q4 2019 in Review
Winfield Associates sold out of bluebird bio (BLUE) in Q4 2019, closing a stake of 198 shares — an estimated $236K sold.
Winfield Associates first reported a position in BLUE in Q2 2014 and held it in 22 quarters. The position peaked at $618K in Q1 2018. 274 funds tracked by Wall St. Rank hold BLUE as of Q4 2019.
- Winfield Associates reported no remaining bluebird bio position as of Q4 2019 after selling out during the quarter.
- Winfield Associates sold 198 bluebird bio shares in Q4 2019, an estimated $236K.
- Winfield Associates first reported a position in bluebird bio in Q2 2014 and held it in 22 quarters.
- Winfield Associates's bluebird bio position peaked at $618K in Q1 2018.
- 274 funds tracked by Wall St. Rank held bluebird bio as of Q4 2019.
Based on Winfield Associates's 13F filing for Q4 2019, filed 13 Jan 2020.